Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Oct 4;327(7418):785-9.
doi: 10.1136/bmj.327.7418.785.

Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals

Affiliations
Review

Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals

Suezann Puffer et al. BMJ. .

Abstract

Objective: To examine the prevalence of a risk of bias associated with the design and conduct of cluster randomised controlled trials among a sample of recently published studies.

Design: Retrospective review of cluster randomised trials published in the BMJ, Lancet, and New England Journal of Medicine from January 1997 to October 2002.

Main outcome measures: Prevalence of secure randomisation of clusters, identification of participants before randomisation (to avoid foreknowledge of allocation), differential recruitment between treatment arms, differential application of inclusion and exclusion criteria, and differential attrition.

Results: Of the 36 trials identified, 24 were published in the BMJ,11 in the Lancet, and a single trial in the New England Journal of Medicine. At the cluster level, 15 (42%) trials provided evidence for secure allocation and 25 (69%) used stratified allocation. Few trials showed evidence of imbalance at the cluster level. However, some evidence of susceptibility to risk of bias at the individual level existed in 14 (39%) studies.

Conclusions: Some recently published cluster randomised trials may not have taken adequate precautions to guard against threats to the internal validity of their design.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Shulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials in obstretrics and gynaecology journals. JAMA 1994;272: 125-8. - PubMed
    1. Kjaergaard LL, Villumsen J, Cluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135: 982-9. - PubMed
    1. Schulz KF. Subverting randomisation in controlled trials. JAMA 1995;274: 1456-8. - PubMed
    1. Zelen M. Randomized consent designs for clinical trials: an update. Stat Med 1990;9: 645-56. - PubMed
    1. Altman DG, Whitehead J, Parmar MKB, Stenning SP, Fayers PM, Machin D. Randomised consent designs in cancer clinical trials. Eur J Cancer 1995;31A: 1934-44. - PubMed

Publication types

MeSH terms